PRESCRIBING · PART D · 2024
Total Rx claims
268
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
7
Brand share
36.2%
Top prescribed drugs
Osimertinib Mesylate80 claims
Ondansetron Hcl60 claims
Prochlorperazine Maleate49 claims
Oxycodone Hcl26 claims
Dexamethasone21 claims
QUALITY · MIPS · 2024
Final MIPS score
88.0
Quality
74.0
Cost
71.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.55%
Group
CROSS-REFERENCE